79 Wellington St W, Suite 3000, Box 270, TD Ctr, Toronto, ON
Year called to bar: 2007 (ON)
Teresa provides ongoing advice to clients who sell regulated products in the food, pharmaceutical, biotechnology and medical device industries. She advises on intellectual property and regulatory issues in the chemical, biochemical and pharmaceutical fields, including the validity patentability and infringement of intellectual property rights. Teresa has extensive experience with drafting, filing and prosecuting patent applications and is frequently involved in drafting and negotiating IP licensing, research and development, co-promotion, marketing and confidentiality agreements for her clients. She also provides guidance on Food and Drugs Act compliance, establishment licensing, product licensing, packaging and labeling, drug pricing and formulary listings. She has deep knowledge in the advertising and promotion of consumer products, food and health products, as well as mandatory reporting and corrective actions. Her work regularly includes advising clients across industries on privacy issues, cross-border transfer of personal information and compliance with privacy law obligations, particularly involving personal health information. Teresa is a Registered Patent Agent in Canada.
On July 17, 2017, Norgine B.V., a European specialist pharmaceutical company, acquired all issued and outstanding shares of Merus Labs International Inc. (Merus), pursuant to a plan of arrangement for $1.65 per common share in cash, including the assumption of all debt obligations, for a total enterprise value of approximately $342 million.